Clinical Publications

Clinical Publications

Progenity conducts and publishes ongoing research, to encourage open sharing of ideas and information that can lead to better patient care.

Cell-free DNA screening is specially designed to tell you about fetal chromosome abnormalities. But did you know it will sometimes tell you something clinically significant about mom?

At inception, the ability to detect aneuploidy in twin pregnancies using cell-free DNA (cfDNA) was rightfully doubted. But there is now increasing data supporting the use of cfDNA screening for twin pregnancies.

Innatal noninvasive prenatal screening is backed by a peer-reviewed, high powered study.

Zoom in from full chromosome to single nucleotide with a new application for cell-free DNA (cfDNA) technology. Expand your patients’ prenatal options with the Resura® Prenatal Test.

Did you know maternal blood chimerism can be detected during cell-free DNA screening? Neither did we, until this happened.

Know more. Learn how we have improved our Innatal® Prenatal Screen.

Confirming sex chromosome abnormalities and predicting clinical implications can be trickier than you think. Here’s one case series that proves this point.